<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font19">NoV </span>
   <span class="font16">that </span>
   <span class="font15">vaccine </span>
   <span class="font15">was </span>
   <span class="font14">with </span>
   <span class="font14">for </span>
   <span class="font14">:â€". </span>
   <span class="font13">(). </span>
   <span class="font13">are </span>
   <span class="font12">al.. </span>
   <span class="font12">norovirus </span>
   <span class="font12">GII. </span>
   <span class="font12">were </span>
   <span class="font12">have </span>
   <span class="font12">infection </span>
   <span class="font12">from </span>
   <span class="font12">{background </span>
   <span class="font12">been </span>
   <span class="font12">can </span>
   <span class="font12">immune </span>
   <span class="font12">Norovirus </span>
   <span class="font11">GI. </span>
   <span class="font11">vaccines </span>
   <span class="font11">However, </span>
   <span class="font11">against </span>
   <span class="font11">margin </span>
   <span class="font11">not </span>
   <span class="font11">response </span>
   <span class="font11">Infect </span>
   <span class="font11">effective </span>
   <span class="font11">has </span>
   <span class="font11">{border-style </span>
   <span class="font11">The </span>
   <span class="font11">antibody </span>
   <span class="font11">bivalent </span>
   <span class="font11">development </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Dis. </span>
   <span class="font11">Moreover, </span>
   <span class="font11">this </span>
   <span class="font11">years </span>
   <span class="font11">(NoV) </span>
   <span class="font11">both </span>
   <span class="font11">disease </span>
   <span class="font11">protection </span>
   <span class="font11">subjects </span>
   <span class="font11">those </span>
   <span class="font11">virus </span>
   <span class="font11">when </span>
   <span class="font11">AGE </span>
   <span class="font11">VLPs </span>
   <span class="font11">these </span>
   <span class="font11">adults </span>
   <span class="font11">after </span>
   <span class="font11">most </span>
   <span class="font11">studies </span>
   <span class="font11">other </span>
   <span class="font11">shown </span>
   <span class="font11">than </span>
   <span class="font10">This </span>
   <span class="font10">all </span>
   <span class="font10">containing </span>
   <span class="font10">due </span>
   <span class="font10">levels </span>
   <span class="font10">particle </span>
   <span class="font10">two </span>
   <span class="font10">NoV-specific </span>
   <span class="font10">acute </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">some </span>
   <span class="font10">study </span>
   <span class="font10">viral </span>
   <span class="font10">GII </span>
   <span class="font10">VLP </span>
   <span class="font10">Vaccine </span>
   <span class="font10">antigens </span>
   <span class="font10">associated </span>
   <span class="font10">burden </span>
   <span class="font10">cause </span>
   <span class="font10">children </span>
   <span class="font10">common </span>
   <span class="font10">gastroenteritis </span>
   <span class="font10">genotypes </span>
   <span class="font10">higher </span>
   <span class="font10">human </span>
   <span class="font10">induce </span>
   <span class="font10">infections </span>
   <span class="font10">only </span>
   <span class="font10">particles </span>
   <span class="font10">which </span>
   <span class="font10">Î¼g </span>
   <span class="font10">Virol. </span>
   <span class="font10">adenovirus </span>
   <span class="font10">cases </span>
   <span class="font10">challenge </span>
   <span class="font10">could </span>
   <span class="font10">found </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">incidence </span>
   <span class="font10">patients </span>
   <span class="font10">phase </span>
   <span class="font10">responses </span>
   <span class="font10">risk </span>
   <span class="font10">virus-like </span>
   <span class="font10">./j.vaccine... </span>
   <span class="font10">:e. </span>
   <span class="font10">Finally, </span>
   <span class="font10">IgA </span>
   <span class="font10">Vaccine. </span>
   <span class="font10">able </span>
   <span class="font10">although </span>
   <span class="font10">antibodies </span>
   <span class="font10">any </span>
   <span class="font10">capsid </span>
   <span class="font10">diarrhea </span>
   <span class="font10">group </span>
   <span class="font10">included </span>
   <span class="font10">increase </span>
   <span class="font10">outbreaks </span>
   <span class="font10">problems </span>
   <span class="font10">px; </span>
   <span class="font10">specific </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€" </span>
   <span class="font10">Development </span>
   <span class="font10">HBGA-blocking </span>
   <span class="font10">Vaccines </span>
   <span class="font10">age </span>
   <span class="font10">among </span>
   <span class="font10">based </span>
   <span class="font10">clinical </span>
   <span class="font10">doses </span>
   <span class="font10">even </span>
   <span class="font10">font-size </span>
   <span class="font10">healthy </span>
   <span class="font10">infection. </span>
   <span class="font10">lower </span>
   <span class="font10">more </span>
   <span class="font10">norwalk </span>
   <span class="font10">recent </span>
   <span class="font10">recombinant </span>
   <span class="font10">rotavirus </span>
   <span class="font10">same </span>
   <span class="font10">serum </span>
   <span class="font10">strain </span>
   <span class="font10">strains </span>
   <span class="font10">systematic </span>
   <span class="font10">vaccine, </span>
   <span class="font10">years, </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">Clin </span>
   <span class="font10">PLoS </span>
   <span class="font10">cells </span>
   <span class="font10">cellular </span>
   <span class="font10">combination </span>
   <span class="font10">combined </span>
   <span class="font10">compared </span>
   <span class="font10">contrast, </span>
   <span class="font10">countries </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">given </span>
   <span class="font10">global </span>
   <span class="font10">heterologous </span>
   <span class="font10">high </span>
   <span class="font10">including </span>
   <span class="font10">increased </span>
   <span class="font10">induced </span>
   <span class="font10">old </span>
   <span class="font10">preparation </span>
   <span class="font10">preparations </span>
   <span class="font10">protein </span>
   <span class="font10">received </span>
   <span class="font10">related </span>
   <span class="font10">reported </span>
   <span class="font10">revealed </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">trial </span>
   <span class="font10">use </span>
   <span class="font10">vaccination </span>
   <span class="font10">viruses </span>
   <span class="font10">(), </span>
   <span class="font10">NoV, </span>
   <span class="font10">Norwalk </span>
   <span class="font10">analysis </span>
   <span class="font10">animal </span>
   <span class="font10">animals </span>
   <span class="font10">because </span>
   <span class="font10">before </span>
   <span class="font10">between </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">candidate </span>
   <span class="font10">cell </span>
   <span class="font10">days </span>
   <span class="font10">developed </span>
   <span class="font10">developed. </span>
   <span class="font10">differences </span>
   <span class="font10">evaluate </span>
   <span class="font10">evidenced </span>
   <span class="font10">expressing </span>
   <span class="font10">formulation </span>
   <span class="font10">frequently </span>
   <span class="font10">had </span>
   <span class="font10">health </span>
   <span class="font10">highly </span>
   <span class="font10">identification </span>
   <span class="font10">illness </span>
   <span class="font10">influenza </span>
   <span class="font10">lead </span>
   <span class="font10">led </span>
   <span class="font10">mainly </span>
   <span class="font10">may </span>
   <span class="font10">mice. </span>
   <span class="font10">must </span>
   <span class="font10">number </span>
   <span class="font10">one </span>
   <span class="font10">potential </span>
   <span class="font10">potentially </span>
   <span class="font10">prevention </span>
   <span class="font10">protective </span>
   <span class="font10">receiving </span>
   <span class="font10">results </span>
   <span class="font10">role </span>
   <span class="font10">safe </span>
   <span class="font10">solid; </span>
   <span class="font10">such </span>
   <span class="font10">susceptibility </span>
   <span class="font10">system </span>
   <span class="font10">used </span>
   <span class="font10">whether </span>
   <span class="font10">will </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.), </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">Clinical </span>
   <span class="font10">FUT </span>
   <span class="font10">GII., </span>
   <span class="font10">Genetic </span>
   <span class="font10">Intranasal </span>
   <span class="font10">ONE. </span>
   <span class="font10">Studies </span>
   <span class="font10">VLPs, </span>
   <span class="font10">Vaxart </span>
   <span class="font10">adjuvanted </span>
   <span class="font10">administration </span>
   <span class="font10">age. </span>
   <span class="font10">aged </span>
   <span class="font10">antigenic </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">availability </span>
   <span class="font10">bold </span>
   <span class="font10">but </span>
   <span class="font10">capable </span>
   <span class="font10">collected </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">delivery </span>
   <span class="font10">derived </span>
   <span class="font10">develop </span>
   <span class="font10">diarrhoeal </span>
   <span class="font10">domain </span>
   <span class="font10">dose </span>
   <span class="font10">during </span>
   <span class="font10">economic </span>
   <span class="font10">em; </span>
   <span class="font10">episodes </span>
   <span class="font10">extremely </span>
   <span class="font10">further </span>
   <span class="font10">gastroenteritis. </span>
   <span class="font10">genotype </span>
   <span class="font10">genotype. </span>
   <span class="font10">immunity </span>
   <span class="font10">immunization </span>
   <span class="font10">infection, </span>
   <span class="font10">infectious </span>
   <span class="font10">intestinal </span>
   <span class="font10">intramuscular </span>
   <span class="font10">intranasal </span>
   <span class="font10">its </span>
   <span class="font10">know </span>
   <span class="font10">level </span>
   <span class="font10">many </span>
   <span class="font10">memory </span>
   <span class="font10">mild </span>
   <span class="font10">models </span>
   <span class="font10">monovalent </span>
   <span class="font10">occur </span>
   <span class="font10">oral </span>
   <span class="font10">people </span>
   <span class="font10">population </span>
   <span class="font10">possible </span>
   <span class="font10">protection. </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates </span>
   <span class="font10">reduced </span>
   <span class="font10">response, </span>
   <span class="font10">several </span>
   <span class="font10">severe </span>
   <span class="font10">similar </span>
   <span class="font10">single </span>
   <span class="font10">slightly </span>
   <span class="font10">solved </span>
   <span class="font10">tested </span>
   <span class="font10">their </span>
   <span class="font10">they </span>
   <span class="font10">total </span>
   <span class="font10">trials </span>
   <span class="font10">vaccine. </span>
   <span class="font10">weeks </span>
   <span class="font10">where </span>
   <span class="font10">younger </span>
  </p>
 </body>
</html>
